Derivative Assay:Article Title: A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus
Article Snippet: .. Overall, these results demonstrate synergism of three antibiotics, gentamicin, ciprofloxacin, and daptomycin, belonging to varied classes, when combined with IAFGP or P1. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC. .. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC.
Plasmid Preparation:Article Title: A Tick Antivirulence Protein Potentiates Antibiotics against Staphylococcus aureus
Article Snippet: .. Overall, these results demonstrate synergism of three antibiotics, gentamicin, ciprofloxacin, and daptomycin, belonging to varied classes, when combined with IAFGP or P1. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC. .. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic tested MIC (μg/ml) MIC (μg/ml) + 0.1 mg/ml IAFGP c MIC (μg/ml) + 0.1 mg/ml P1 c SA113 a USA300 b SA113 USA300 SA113 USA300 Gentamicin 0.63–1.25 1.25–2.5 0.16–0.31 0.31–0.63 0.08–0.16 0.31–0.63 Ciprofloxacin 1.25–2.5 R 0.31–0.63 R 0.16–0.31 R Daptomycin 1.25–2.5 2.5–5 0.08–0.16 0.08–0.16 0.08–0.16 0.08–0.16 Open in a separate window a SA113 S. aureus strain (ATCC 35556) is derived from laboratory strain NCTC 8325. b MRSA isolate USA300 JE2 is a plasmid-cured derivative of strain LAC.
Mann-Whitney U-Test:Article Title: Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model
Article Snippet: .. *, P < 0.05; **, P < 0.01; ns, P > 0.05 by Mann-Whitney U test. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic a Phenotype b MIC (mg/liter) Interpretive category (EUCAST/CLSI) c CRO WT 0.125 S/S MUT 0.125 S/S CIP WT 0.016 S/S MUT 0.016 S/S GEN WT 0.125 S/S MUT 1 S/S Open in a separate window a CRO, ceftriaxone; CIP, ciprofloxacin; GEN, gentamicin. b WT, wild type (ATCC 25922); MUT, mutant (ALO 4783). c S, susceptible. ..
Mutagenesis:Article Title: Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model
Article Snippet: .. *, P < 0.05; **, P < 0.01; ns, P > 0.05 by Mann-Whitney U test. table ft1 table-wrap mode="anchored" t5 TABLE 1 caption a7 Antibiotic a Phenotype b MIC (mg/liter) Interpretive category (EUCAST/CLSI) c CRO WT 0.125 S/S MUT 0.125 S/S CIP WT 0.016 S/S MUT 0.016 S/S GEN WT 0.125 S/S MUT 1 S/S Open in a separate window a CRO, ceftriaxone; CIP, ciprofloxacin; GEN, gentamicin. b WT, wild type (ATCC 25922); MUT, mutant (ALO 4783). c S, susceptible. ..
In Vitro:Article Title: Impact of Therapeutic Treatment with β-Lactam on Transfer of the bla CTX-M-9 Resistance Gene from Salmonella enterica Serovar Virchow to Escherichia coli in Gnotobiotic Rats
Article Snippet: .. Transconjugants were considered to be ESBL-positive strains at the epidemiological EUCAST cutoff value. table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Antibiotic Note a Susceptibility (S) or resistance (R) (MIC [μg/ml]) E. coli ATCC 25922 Donor S. enterica serovar Virchow 3464b Recipient E. coli J5 E. coli J5(p3464b) transconjugant in vitro b E. coli J5(p3464b) transconjugant b Before treatment 7 days posttreatment 12 days posttreatment Amoxicillin-clavulanic acid A, D S (4) R (8) S (4) R (8) R (32) R (32) R (32) Ampicillin A, D, E S (4) R (128) S (4) R (128) R (64) R (32) R (32) Cefixime B, D, E S (0.13) R (8) S (0.13) R (8) R (8) R (8) R (8) Cefotaxime A, C, E S (0.03) R (>8) S (0.03) R (8) R (0.50) R (0.50) R (1) Cefoxitin A, C S (4) S (16) S (4) S (4) R (32) S (16) S (16) Ceftazidime A, C, E S (0.13) R (8) S (0.13) R (2) R (4) R (2) R (2) Ceftiofur A, C, E S (0.25) R (>8) S (0.25) R (8) R (1) R (1) R (1) Cefuroxime A, C, E S (2) R (>32) S (2) R (32) R (32) R (32) R (32) Nalidixic acid A, D S (4) R (256) S (4) S (4) S (4) S (8) S (8) Streptomycin A, C S (2) R (128) S (2) R (16) S (2) S (2) S (2) Sulfamethoxazole A, D S (8) R (>512) S (8) R (>512) S (8) S (32) S (32) Tetracycline A, D S (1) R (64) S (1) R (16) S (1) S (2) S (2) Trimethoprim A, D S (0.50) R (>64) S (0.50) R (16) S (0.50) S (1) S (1) Trimethoprim-sulfamethoxazole A, D S (<1) R (>16) S (<1) R (16) S (1) S (1) S (1) Open in a separate window a A, the MICs of antimicrobial agents were determined by the broth microdilution method; B, the MICs of cefixime were determined with Etest strips; C, results were interpretative of susceptible or resistant strains according to the criteria proposed by EUCAST; D, results were interpretative of susceptible or resistant strains according to the criteria proposed by CLSI; E, resistance to this antibiotic was presumably mediated by CTX-M-9 enzyme. b The MICs of one of the four isolated transconjugants are presented in the table (all transconjugants have the same susceptibility values). ..
Isolation:Article Title: Impact of Therapeutic Treatment with β-Lactam on Transfer of the bla CTX-M-9 Resistance Gene from Salmonella enterica Serovar Virchow to Escherichia coli in Gnotobiotic Rats
Article Snippet: .. Transconjugants were considered to be ESBL-positive strains at the epidemiological EUCAST cutoff value. table ft1 table-wrap mode="anchored" t5 TABLE 2. caption a7 Antibiotic Note a Susceptibility (S) or resistance (R) (MIC [μg/ml]) E. coli ATCC 25922 Donor S. enterica serovar Virchow 3464b Recipient E. coli J5 E. coli J5(p3464b) transconjugant in vitro b E. coli J5(p3464b) transconjugant b Before treatment 7 days posttreatment 12 days posttreatment Amoxicillin-clavulanic acid A, D S (4) R (8) S (4) R (8) R (32) R (32) R (32) Ampicillin A, D, E S (4) R (128) S (4) R (128) R (64) R (32) R (32) Cefixime B, D, E S (0.13) R (8) S (0.13) R (8) R (8) R (8) R (8) Cefotaxime A, C, E S (0.03) R (>8) S (0.03) R (8) R (0.50) R (0.50) R (1) Cefoxitin A, C S (4) S (16) S (4) S (4) R (32) S (16) S (16) Ceftazidime A, C, E S (0.13) R (8) S (0.13) R (2) R (4) R (2) R (2) Ceftiofur A, C, E S (0.25) R (>8) S (0.25) R (8) R (1) R (1) R (1) Cefuroxime A, C, E S (2) R (>32) S (2) R (32) R (32) R (32) R (32) Nalidixic acid A, D S (4) R (256) S (4) S (4) S (4) S (8) S (8) Streptomycin A, C S (2) R (128) S (2) R (16) S (2) S (2) S (2) Sulfamethoxazole A, D S (8) R (>512) S (8) R (>512) S (8) S (32) S (32) Tetracycline A, D S (1) R (64) S (1) R (16) S (1) S (2) S (2) Trimethoprim A, D S (0.50) R (>64) S (0.50) R (16) S (0.50) S (1) S (1) Trimethoprim-sulfamethoxazole A, D S (<1) R (>16) S (<1) R (16) S (1) S (1) S (1) Open in a separate window a A, the MICs of antimicrobial agents were determined by the broth microdilution method; B, the MICs of cefixime were determined with Etest strips; C, results were interpretative of susceptible or resistant strains according to the criteria proposed by EUCAST; D, results were interpretative of susceptible or resistant strains according to the criteria proposed by CLSI; E, resistance to this antibiotic was presumably mediated by CTX-M-9 enzyme. b The MICs of one of the four isolated transconjugants are presented in the table (all transconjugants have the same susceptibility values). ..
|